Drugs Made In America Acquisition Corp. is a blank check company formed to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses, with an intended focus on the pharmaceutical industry. It has no significant operations of its own and maintains capital in a trust account until a suitable target is identified and the transaction completed.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 0 | — | 2.3 | — |
| Q3 2025 | 0 | — | 2.2 | — |
| Q4 2025 | 0 | — | 0.2 | — |
| Q1 2026 | 0 | — | 2 | — |
| Q2 2026 | 0 | — | 1.7 | -24.5% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Neighborhood Intelligence, Inc. (NXH), Reading International, Inc. (RDIB), Oaktree Acquisition Corp. III Life Sciences (OACC), Lantronix, Inc. (LTRX), Syntec Optics Holdings, Inc. (OPTX), Hall Chadwick Acquisition Corp. (HCACU)